Introduction
============

Infertility is defined as the failure to conceive after 1 year of regular, unprotected intercourse.[@b1-ijwh-3-329] This condition affects up to one in seven couples in industrialized countries,[@b2-ijwh-3-329] and it is one of the most prevalent chronic health disorders involving young adults.[@b3-ijwh-3-329]

Several methods have been introduced to help infertile couples conceive, including intracytoplasmic sperm injection (ICSI). ICSI was introduced in 1992 as a solution for male infertility[@b4-ijwh-3-329] and in 2007, ICSI represented 48% of all in vitro fertilization treatments in the UK.[@b5-ijwh-3-329] In this procedure, a single sperm is injected directly into the oocyte cytoplasm, and it represents a very effective therapy option in men with very low sperm counts. The clinical pregnancy rates after ICSI have been reported to reach 39.2% per embryo transfer,[@b6-ijwh-3-329] and the overall success of ICSI seems dependent on factors such as sperm retrieval method,[@b7-ijwh-3-329] maternal age, and whether the infertility is primary or secondary.[@b8-ijwh-3-329] In addition, miscarriage significantly reduces the initial success of assisted reproduction treatment.[@b9-ijwh-3-329]

Early pregnancy loss (EPL) after ICSI has been linked to obesity and increased maternal age.[@b10-ijwh-3-329] However, additional unknown barriers affect the efficiency of ICSI treatment and require further research.

*Helicobacter pylori* infection affects more than half of the world's population,[@b11-ijwh-3-329] and is most commonly associated with chronic gastritis, which subsequently increases the risk of many serious complications, including gastric cancer.[@b12-ijwh-3-329] Additionally, there are limited reports indicating potential correlation between infertility and *H. pylori* infection.[@b13-ijwh-3-329],[@b14-ijwh-3-329] It has been shown in mice that *H. pylori* infected mice show a decrease in implantation rates, and their offspring are of low birth weight.[@b15-ijwh-3-329] In infertile human males, *H. pylori* infection was shown to be associated with low sperm quality compared to uninfected patients.[@b14-ijwh-3-329]

The pathogenicity of an *H. pylori* isolate depends on strain-specific factors.[@b16-ijwh-3-329] The cag pathogenicity island, for which cytotoxin-associated gene A (CagA) is the marker, has been associated with both duodenal ulcer and gastric cancer,[@b17-ijwh-3-329] and infection with CagA-positive strain is generally associated with a higher level of inflammatory mediators compared to CagA-negative strains.

In CagA-positive male patients, a significant reduction in sperm motility was observed along with increased apoptosis and necrosis[@b14-ijwh-3-329] but no studies describing potential role of maternal *H. pylori* infection in pregnancy course exist. Should the detrimental effect of *H. pylori* on pregnancies conceived by assisted reproductive technology (ART) be confirmed, appropriate treatment of *H. pylori* infection prior to ART treatment could improve the treatment success.

Our aim was to investigate the link between maternal *H. pylori* infection and implantation rates and EPL in patients undergoing ICSI.

Methods
=======

Participants
------------

Between January 2009 and September 2009, we did a prospective cohort study, to which we consecutively enrolled women undergoing ICSI at the Centre for Treatment and Research in Infertility of Shahid Mottahari hospital in Urmia, Iran. The Centre for Treatment and Research in Infertility is the only infertility clinic in the West Azarbaijan province of Iran, and all infertile patients in the area are referred to this centre. All patients were of similar age and lived in the same region. Patients' infertility was defined as a failure to conceive after 1 year of unprotected intercourse.

The study was approved by the university Institutional Review Board and Ethics Committee. Informed written consent was obtained from all participants in the presence of a witness. The study is summarized in a flowchart ([Figure 1](#f1-ijwh-3-329){ref-type="fig"}).

Procedures
----------

We treated women undergoing ICSI with standard clinical and laboratory protocols.

Briefly, couples initially underwent routine fertility work-up consisting of semen analysis, sonohysterography and female hormone testing (luteinizing hormone \[LH\], follicle stimulating hormone \[FSH\], prolactin, thyroid stimulating hormone \[TSH\], estradiol). Hormone levels were evaluated on the third day of the patient's menstrual cycle.

Ovarian stimulation with gonadotropin-releasing hormone (GnRH) agonist buserelin acetate (Suprefact^®^; Hoechst AG, Frankfurt, Germany), at a dose between 0.3--0.5 mg/SC, was started during the midluteal phase in a long protocol manner starting on the 21st day of the previous cycle. Then a daily injection of human menopausal gonadotropin (HMG) (Menogon^®^, Ferring, Kiel, Germany) was administered and the GnRH dose was lowered to 50% upon the administration of HMG.

The dose of HMG was increased in accordance with individual patient's response and in accordance with a series of transvaginal sonographic observations until at least two follicles reached a mean diameter of 18 mm. Then 5000--10000 IU of HCG (Pregnyl^®^, Merck/Schering-Plough Pharmaceuticals Inc, Sumneytown Pike, North Wales) was injected intramuscularly and after 34--36 hours, transvaginal ultrasound-guided oocyte retrieval was performed.

Spermatocyte preparation
------------------------

Ejaculates were obtained immediately before or shortly after oocyte retrieval.

In cases of obstructive and non-obstructive azoospermia, spermatozoa were obtained by microsurgical epididymal sperm aspiration (MESA) or testicular sperm extraction (TESE), respectively.

Intracytoplasmic sperm injection
--------------------------------

Oocytes were microscopically examined for the presence of cytoplasmic abnormalities before sperm injection. ICSI treatment was performed 5--8 hours after oocyte retrieval.

The technique of ICSI has previously been described in detail.[@b18-ijwh-3-329] In brief, at a magnification of ×400, a single spermatozoon was immobilized by mechanical damage to its tail. Prior to ICSI, the oocyte was held in place with a holding pipette (Eppendorf, Hamburg, Germany) at 9 O'clock. The first polar body was located on the 6 O'clock position. After penetrating both the zona pellucida and the oolemma, a small volume of the oocyte cytoplasm was aspirated to activate the egg. The previously immobilized spermatozoon was placed near the horizontal axis. Withdrawal was conducted carefully to prevent leakage from the oocyte. One embryologist performed all ICSI treatments.

After sperm injection, fertilized oocytes were placed in individual culture media dishes in an incubator (Labotech, Berlin, Germany), using an environment with 5% CO~2~, at 37°C, in a filtered humidified atmosphere. Normal fertilization and survival was assessed at 14--18 hours after sperm injection.

If at least one embryo of grade A to C was identified 48--72 hours after ovarian puncture, it was transferred into the uterine cavity.

Embryo grading
--------------

Prior to the transfer procedure (approximately 48 hours post-insemination), the embryo development and morphology were determined, and the embryos for transfer were selected. Each embryo was assessed according to the blastomere number, the degree of fragmentation, the uniformity of blastomeres, and the presence of multinucleated blastomeres.

### Intracytoplasmic sperm injection (ICSI)

Grade A were embryos with equally sized blastomeres, cells without granulation, and with regular zona pellucida. Grade B were those with equally divided cells and ≤10% granulation. Grade C were those with unequal cells and 20% granulation. Embryos with unequally-sized blastomeres or \>20% fragments, unequally-sized blastomeres or \>50% fragments, and \>80% fragmentation or with no detectable blastomeres were not transferred.

Patient follow-up after embryo transfer
---------------------------------------

Patients received 30 mg of intramuscular progesterone twice-a-day (progesterone 50 mg/IM, Aburaihan Co, Tehran, Iran) after embryo transfer, to reinforce the luteal phase. Serum human chorionic gonadotropin (hCG) was measured 14--15 days post-transfer.

In those with a positive hCG response, we measured hCG again after 2 days. Patients were followed for 12 weeks sonographically to determine early abortion (week 4, 6, 9, 12).

Determination of antibodies against *H. pylori*
-----------------------------------------------

Complete blood count (CBC) is an integral part of the routine check-up prior to surgery for all patients undergoing ICSI. Upon drawing blood for CBC, an additional 2 mL of patients' blood were taken for *H. pylori* IgG assessment. The blood was centrifuged and the serum was kept at −20°C until the day of examination.

The status of *H. pylori* IgG was determined serologically using enzyme-linked immunosorbent assay (ELISA) (Serum Anti-*H. pylori* IgG, *H. pylori* CagA-Ig, Diaplus Inc, North York, ON). Titer levels \> 20 for IgG and \> 5 for CagA were considered positive. If a patient was positive for anti-*H.pylori* IgG, she also underwent further assessment to determine the anti-CagA IgG status.

Statistical analysis
--------------------

Statistical analysis was performed using SPSS (v 16; IBM, Chicago, IL) and R package (<http://www.r-project.org>). We used a logistic regression to predict EPL from age, *H. pylori* status, CagA positivity, underlying infertility etiology, number of oocytes obtained, number of embryos formed, and number of transferred embryos. A *P*-value less than or equal to 0.05 was considered statistically significant.

Results
=======

We enrolled 187 and assessed 150 women undergoing ICSI for pregnancy rates, *H. pylori* seropositivity, and EPL. The mean age of participating women was 30.6 years (SD 5.8). The mean age of women who conceived after ICSI and of women who were unable to conceive after ICSI was significantly different (*P* \< 0.0001, unpaired *t*-test).

Seventeen couples (11%) had secondary infertility and 133 (89%) primary infertility. The primary diagnosis of infertility was male factors: oligospermia (sperm count \<5 million); asthenospermia (forward sperm motility \< 5%); teratospermia (normal sperm morphology \< 4%); obstructive azoospermia and non-obstructive azoospermia; retrograde ejaculation; and immunologic factors in 81 (54%) couples, followed by tubal factor (laparoscopically diagnosed bilateral tubal obstruction) in 11 (7%); ovulation disorders (patients not responding to ovulation stimulation, intrauterine insemination (IUI), and with high FSH levels) in 17 (11%); and idiopathic infertility in 41 (27%) ([Figure 2](#f2-ijwh-3-329){ref-type="fig"}). In women receiving embryos, 47 (31%) had one embryo transferred, 40 (27%) had two embryos transferred, 48 (32%) had three transferred, eight (5.3%) had four transferred and seven (4.6%) had five or more transferred.

We excluded from the study and final analysis ([Table 1](#t1-ijwh-3-329){ref-type="table"}) women with unilateral or bilateral hydrosalpinx (n = 1), ovarian cyst formation following the GnRH administration diagnosed by TVS on the 2nd day of the menstrual cycle (n = 2), history of pregnancy loss (n = 2), ectopic pregnancy following ICSI (n = 4), endometriosis (n = 3), patients who in the previous 3 months took medications that might lead to false negative results (eg, tetracycline and omeprazole, n = 4). We also excluded patients with no follicles or less than two follicles formed after ovarian stimulation (n = 3), and with one or no oocyte obtained at follicle puncture (n = 5).

Fifty-eight patients (39%) were positive for IgG antibodies against *H. pylori*, while 92 patients (61%) were negative. Nineteen patients (13%) with IgG against *H. pylori* were also positive for CagA. Using a linear model, we noted a significant association between IgG positivity and maternal age (1.01, 95% confidence interval \[CI\]: 1.0--1.13; *P* = 0.040; but not CagA positivity; *P* = 0.41).

We noted a significant association between CagA positivity and EPL (19.39, 95% CI: 1.8--208.4; *P* = 0.014).

There was a significant association between EPL and underlying infertility etiology (12.95, 95% CI: 1.28--131.11, *P* = 0.03 for tubal factor, 10.84, 95% CI: 1.47--80.03, *P* = 0.02 for ovulation disorder).

Out of 58 patients with *H. pylori* infection, 23 became pregnant after ICSI, and among 92 *H. pylori* negative patients, 27 became pregnant (1.58, 95% CI: 0.79--3.16; *P* = 0.19). This indicates that *H. pylori* infection does not affect pregnancy rates after ICSI.

Among 23 *H. pylori* positive pregnant women, seven (30%) were also positive for CagA strains, and among 35 *H. pylori* positive women that did not conceive after ICSI, 12 (34%) were also positive for CagA. There was no significant link between CagA infection and pregnancy following ICSI (0.83, 95% CI: 0.26--2.56; *P* = 0.76).

Discussion
==========

Our findings indicate that infection with CagA strains of *H. pylori* is associated with EPL following ICSI. The likelihood of EPL also increases with tubal factor and ovulatory disorder as the underlying infertility etiology. The pregnancy rates were not affected by *H. pylori* infection nor CagA positivity, but were affected by maternal age (*P* = 0.0001).

We also observed a statistically significant link between the increase in age and *H. pylori* infection in infertile women (*P* = 0.040), which has not been reported previously.

This finding may indeed reflect the trend described previously in children, general population couples, and Welsh men,[@b19-ijwh-3-329] which suggests that the prevalence of *H. pylori* infection generally increases with age.[@b20-ijwh-3-329] Since age has been reported to contribute to the increase of EPL after ICSI, we may hypothesize that undetected CagA-positive *H. pylori* infection among subjects in those studies may have been an additional factor underlying this observed trend. We observed no association between EPL and maternal age (*P* = 0.15).

Although ICSI is an efficient solution for many infertile couples, it is generally accompanied by high rates of EPL, ranging from 12% to 48%.[@b21-ijwh-3-329] EPL not only significantly reduces the efficiency of the treatment, it also increases the psychological burden on patients undergoing the procedure.[@b21-ijwh-3-329]

Various factors have been comprehensively reported to contribute to EPL in ICSI, including overweight,[@b22-ijwh-3-329] ovarian stimulation with GnRH antagonists,[@b23-ijwh-3-329] maternal age,[@b9-ijwh-3-329] smoking, and the transfer of poor quality embryos.[@b21-ijwh-3-329] Based on our data, we postulate that other causes of EPL following ICSI include infection with *H. pylori* CagA-positive strains and tubal factor and ovulation disorder.

Recently the evidence indicating the causative role of *H. pylori* infection in pregnancy failure has been rapidly accumulating: In males, it has been shown that *H. pylori* infection may affect semen quality in men with idiopathic infertility,[@b14-ijwh-3-329] with two hypotheses explaining this finding: inflammatory reaction to infection, and the immune reaction between *H. pylori* and the sperm antigen.

It has been demonstrated that CagA-positive strains of *H. pylori* can cause injury to different organ systems including male and female reproductive organs through the release of different inflammatory mediators, such as IL-8, IL-1β, and TNF-α.[@b24-ijwh-3-329] TNF-α is multifunctional cytokine with a regulatory role in many fundamental processes, such as immunologic response, angiogenesis, or apoptosis, and is formed both by the placenta and the uterus. It is also associated with apoptosis in different cell lines including the sperm, and has a negative effect on sperm motility. Increase in TNF-α production can lead to pregnancy failure,[@b25-ijwh-3-329] and TNF-α levels are reportedly high in patients infected with CagA-positive *H. pylori* strains.[@b14-ijwh-3-329],[@b26-ijwh-3-329] It may be assumed that CagA-positive strains of *H. pylori* could increase the rates of EPL through TNF-α-related mechanisms.

Our study has detected a significant correlation between different infertility causes and EPL, specifically ovarian dysfunction and tubal factor. This is the first study to observe such a trend.

Polycystic ovary syndrome (PCOS) has been linked to an increased risk of miscarriage,[@b27-ijwh-3-329] but exact mechanisms related to this observance remain enigmatic. Various factors have been implicated, including dysfunction of the Dicer,[@b29-ijwh-3-329] angiotensin-converting enzyme and plasminogen activator inhibitor-1 gene polymorphisms,[@b30-ijwh-3-329] and interestingly, PCOS has been linked to *H. pylori* infection.[@b31-ijwh-3-329] Although our data do not provide sufficient insight into the exact mechanism underpinning EPL in women with ovarian dysfunction infertility, they demonstrate with high significance that this infertility etiology is an independent risk factor for EPL.

Tubal infertility and EPL has been previously linked to total antioxidant capacity,[@b27-ijwh-3-329] otherwise there is no evidence linking this infertility etiology to EPL, nor there is an evidence linking tubal infertility with *H. pylori*.

The CagA seropositivity in Iran has been reported to reach 72.8%.[@b28-ijwh-3-329] Infection with *H. pylori* CagA-positive strains has been shown to cause a severe inflammatory response and significant neutrophil infiltration in the gastric mucosa.[@b29-ijwh-3-329] Our finding of a statistically significant relationship between CagA-positive strains of *H. pylori* and EPL might be explicable on the basis of general inflammatory reaction to infection. Concentrations of IL-1β, IL-8, and TNF-α were all significantly higher in *H. pylori*-positive gastric mucosa samples.[@b30-ijwh-3-329] These cytokines may cause systemic inflammation that could affect the integrity of the fetoplacental unit and threaten the welfare of the foetus.[@b31-ijwh-3-329] It was shown that poor oral hygiene is associated with a history of miscarriage,[@b31-ijwh-3-329] possibly due to systemic inflammatory response to oral bacterial infection. It may be assumed that a parallel mechanism underpins the EPL in women infected with CagA-positive *H. pylori* strains.

The limitations of our study include the determination of *H. pylori* infection with only one method; although the ELISA kit employed in this study has sensitivity and specificity of about 85%. Additionally, the number of women with CagA-positive strain *H. pylori* infection was relatively low. We also included no paternal variable in the study.

Based on our results, we hypothesize that CagA-positive *H. pylori* strains play a significant role in EPL after ICSI. Since ICSI is generally a very straining, time-consuming, and costly procedure, and the eradication of *H. pylori* is relatively cheap and easy to achieve, we propose that CagA status should be determined in all patients undergoing ICSI, and the infection should be treated in positive patients prior to ICSI.

We also propose a large-scale study to be conducted on the effect of *H. pylori* infection on implantation and EPL in pregnancies conceived naturally, to further elucidate the role of *H. pylori* in pregnancy failure. Further studies are also required to elucidate the role of specific etiologic factors of infertility in EPL and related mechanisms.
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![Pregnancy rates, EPL, and infection with CagA-positive strains distributed across groups with different infertility etiology.\
**Abbreviations:** MF, male factor; UA, unknown etiology; TF, tubal factor; OD, ovulatory dysfunction.](ijwh-3-329f2){#f2-ijwh-3-329}

###### 

Early pregnancy loss related to maternal age, *H. pylori* infection, CagA positivity, underlying infertility etiology (IA), number of oocytes retrieved (OR), number of embryos formed (EF), and number of embryos transferred (ET)

                          **Odds ratio**   **Lower CI**   **Upper CI**   ***P* value**   **Number**
  ----------------------- ---------------- -------------- -------------- --------------- ------------
  Age                     0                0.79           1.04           0.15            150
  IgG positivity          0.47             0.05           4.52           0.52            58
  CagA positivity         19.39            1.8            208.4          0.01\*          19
  Unknown IA              4.68             0.73           29.84          0.1             41
  IA:tubal factor         12.95            1.28           131.11         0.03\*          11
  IA:ovulatory disorder   10.84            1.47           80.03          0.02\*          17
  OR                      0.89             0.66           1.2            0.44            Unknown
  EF                      1.11             0.77           1.61           0.57            Unknown
  ET                      1.17             0.68           2.03           0.57            343
